Cancer BiologyBreast Cancer ResearchPeer-reviewed
Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells
Ashley V. Ward, Duncan Riley, Kirsten E. Cosper…·Carol A. Sartorius
This study identifies lipid metabolic reprogramming in endocrine-resistant breast cancer cells, showing TVB-2640 reduces lipid storage but not cell growth.
21 citationstop 2%